retatrutide mechanism glp-1 gip glucagon triple agonist review 2024 2025 GLP-1s About to Get Outdated? Doctor Explains Source- PMID 37366315 PMID 40960239 While current leading medications like semaglutide and tirzepatide rely on single or dual hormone receptor agonism, introduces a revolutionary Oral GLP-1-Based Therapeutics in the
Description
As per this review, clinical evidence emanating from randomized controlled trials (RCTs) and their attendant meta-analyses underscores that the occurrence of thyroid carcinoma is relatively infrequent, thereby engendering imprecision in effect estimations and consequently a paucity of conclusive and consistent evidence regarding an elevated risk among GLP-1 RAs recipients
doi: 10.1038/s41467-024-52898-y.
8 (10), e76654 (2013)
68 WangY.HeW.WeiW.MeiX.YangM.WangY
